Jonathan Jay Mazelsky - Aug 5, 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President and CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Stock symbol
IDXX
Transactions as of
Aug 5, 2024
Transactions value $
-$77,364
Form type
4
Date filed
8/7/2024, 05:00 PM
Previous filing
Jul 15, 2024
Next filing
Oct 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +384 +0.47% $0.00 81.9K Aug 5, 2024 Direct F1
transaction IDXX Common Stock Tax liability -$77.4K -170 -0.21% $455.08 81.7K Aug 5, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -384 -100% 0 Aug 5, 2024 Common Stock 384 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 22 shares purchased under the Issuer's Employee Stock Purchase Plan on March 29, 2024 and June 28, 2024.
F2 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning August 5, 2020.
F3 Not applicable.